HCV eradication in veterans with underlying mental health disorders and substance use
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 60 (6) , 1037-1043.e3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist TherapyClinical Infectious Diseases, 2019
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Has Access to Hepatitis C Virus Therapy Changed for Patients With Mental Health or Substance Use Disorders in the Direct‐Acting‐Antiviral Period?Hepatology, 2018
- “Why Me?” Understanding the HCV Care Continuum Among People With Serious Mental IllnessPsychiatric Services, 2018
- Hepatitis C in Injection-Drug Users — A Hidden Danger of the Opioid EpidemicNew England Journal of Medicine, 2018
- Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014American Journal of Public Health, 2018
- Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral TherapyAnnals of Hepatology, 2018
- Restrictions of Hepatitis C Treatment for Substance-Using Medicaid Patients: Cost Versus EthicsAmerican Journal of Public Health, 2017
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesAnnals of Internal Medicine, 2015
- A novel program for treating patients with trimorbidityEuropean Journal of Gastroenterology & Hepatology, 2013